RxDoctor Payments DataLook up a doctor →

Richard Moro, PA

Physician Assistant · Plainfield, CTNPI 1700859006

Payments from drug & device makers

$24,728in general payments, 2019–2025

Across 1,505 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • AstraZeneca$2K
  • GSK$2K
  • Boehringer Ingelheim$1K
  • Novo Nordisk$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • plus $13K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie265$3,892
AstraZeneca89$2,139
GSK140$1,810
Boehringer Ingelheim86$1,345
Novo Nordisk88$1,273
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)110$1,215
Phathom Pharmaceuticals, Inc.68$1,072
Bayer47$900
Alkermes, Inc.45$883
Pfizer56$793
Lilly USA, LLC40$744
Axsome Therapeutics, Inc.32$623
Amgen38$568
Takeda Pharmaceuticals U.S.A., Inc.25$504
Corium, LLC33$451
Vanda Pharmaceuticals Inc.21$415
Otsuka America Pharmaceutical, Inc.25$408
Scilex Pharmaceuticals Inc.18$387
Regeneron Healthcare Solutions, Inc.9$372
Biohaven Pharmaceuticals, Inc.18$339
Teva Pharmaceuticals USA, Inc.17$331
Lundbeck LLC20$327
Astellas Pharma US Inc6$321
Supernus Pharmaceuticals, Inc.18$314
Biohaven Pharmaceutical Holding Company Ltd.20$276
Sanofi-aventis U.S. LLC12$228
Corcept Therapeutics11$224
Viatris Specialty LLC6$194
Genentech USA, Inc.16$187
Eisai Inc.15$184
Neurocrine Biosciences, Inc.6$174
Avanir Pharmaceuticals, Inc.8$140
Nestle Healthcare Nutrition Inc.8$140
Novartis8$138
Xeris Pharmaceuticals, Inc.7$123
Abbott6$113
Amarin Pharma, Inc.7$113
Endo Pharmaceuticals Inc.5$110
Ardelyx, Inc.5$106
Merck6$98
Sunovion Pharmaceuticals Inc.8$89
Exact Sciences4$86
Mylan Specialty L.p.4$74
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$63
Currax Pharmaceuticals LLC3$51
Almatica Pharma LLC2$46
Jazz Pharmaceuticals Inc.2$44
Arbor Pharmaceuticals, Inc.3$44
ANI Pharmaceuticals, Inc.2$38
Paratek Pharmaceuticals, Inc.2$37
Impel Pharmaceuticals Inc.2$32
Idorsia Pharmaceuticals US Inc2$31
Johnson & Johnson2$30
Sumitomo Pharma America, Inc.1$25
Ironwood Pharmaceuticals, Inc1$20
Collegium Pharmaceutical, Inc.1$18
Zealand Pharma US, Inc.1$14
Gilead1$14

How this compares

$24,728 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$30,616
Medicare patients
131
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Plainfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →